Study S000231

Investigation of the Cardiovascular Effects of Exenatide in Healthy Male Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01046721
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: TRIPLE
Status: COMPLETED
Enrollment: 8
Start: 2009-09
Primary completion: 2012-12
Lead sponsor: University of Nottingham
Conditions: Type 2 Diabetes
Interventions: DRUG:Exenatide; DRUG:Saline
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

superior mesenteric (SMA) blood flow [0, 30, 60, 90, 120, 150, & 180 min after meal]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0024231	Investigation of the haemodynamic effects of exenatide in healthy male subjects. Mendis B, British journal of clinical pharmacology	2012	Randomized trial	PMID 22320349 DOI	registry reference RESULT:22320349